Drug intelligence / Profile preview

autologous stem cell therapy

Development stage
Unknown
Lead developer
University of Campania Luigi Vanvitelli
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intra-cardiac, Intra-thoracic
01

Overview

Autologous stem cell therapy, as investigated by the University of Campania Luigi Vanvitelli, involves the intra-cardiac infusion of a patient's own stem cells to treat advanced heart failure. This therapeutic approach is specifically designed for patients with chronic heart failure who are refractory to standard medical treatments and have previously received an internal cardioverter-defibrillator (ICD). By delivering stem cells directly into the heart tissue, the treatment aims to stimulate myocardial repair, enhance left ventricular functionality, and reduce the frequency of hospitalizations. Clinical evaluation focuses on improvements in NYHA functional class and the reduction of symptoms such as angina in patients with a history of myocardial infarction and coronary artery revascularization.

Other names
Intra Cardiac Autologous Stem Cells Infusionstem cells infusion

Beyond the preview

Go deeper on autologous stem cell therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous stem cell therapy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call